Sofiva Genomics Co.,Ltd.

NT$32.80As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6615Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR (6.69%)
Div yield —
ROE 2.30%
Diagnostics & Research
Beta (5Y) 0.21
PE TTM 102.4
TSR TTM 2.82%
Mkt cap NT$708.3M
ROIC (2.67%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$34
3.07%
67.02%
Hold 2|5|10|2|6
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.53
0.52
0.52
0.52
14.87%
16.40%
13.04%
0.55%
RevenueNT$M
36.35
37.59
37.71
39.89
10.04%
7.39%
5.42%
8.92%
Peers (US$21.39M)
Cap (US$)
PE
28.26M
52.31x
Capital
TTM
5Y
10Y
Leveragex
1.498
—
0.010
EBIT/Intx
4.522
1.023
1.035
Own earn%
(84.94)
(79.77)
(54.73)
Sh yield%
52.98
46.15
45.29
Owners
Insiders/Inst%
3.99
34.87
Short interest%
3.26
SBC / revenue%
2.82
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
0–3
$1 testx
—
Incr. ROIC%
3